At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HIMS Hims & Hers Health Inc.
Trading 11-06 13:35:31 EST
25.77
+1.71
+7.11%
High25.79Low24.42Vol8.31M
Open25.76D1 Closing24.06Amplitude5.71%
Mkt Cap6.01BTradable Cap5.51BTotal Shares233.31M
T/O210.33MT/O Rate3.89%Tradable Shares213.68M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Earning Preview: Hims & Hers Health Inc. revenue is expected to increase by 53.88%, institutions lean positive
Earnings Agent  ·  11-02
Earning Preview: Hims & Hers Health Inc. revenue is expected to increase by 53.88%, institutions lean positive
Hims & Hers Struck a GLP-1 Deal with Lilly. Its Stock is Rallying.
Dow Jones  ·  00:29
Hims & Hers Struck a GLP-1 Deal with Lilly. Its Stock is Rallying.
Movement Alert｜Hims & Hers Health Inc. Intraday Rise 6.59% in Regular Trading, Eli Lilly partnership expands access to weight-loss drugs
Market Focus  ·  11-06 22:30
Movement Alert｜Hims & Hers Health Inc. Intraday Rise 6.59% in Regular Trading, Eli Lilly partnership expands access to weight-loss drugs
Sector Update: Healthcare Stocks Decline Premarket Friday
MT Newswires Live  ·  11-06 22:20
Sector Update: Healthcare Stocks Decline Premarket Friday
Why Hims & Hers Health Stock was in Dire Need of This Eli Lilly Agreement
Dow Jones  ·  11-06 21:24
Why Hims & Hers Health Stock was in Dire Need of This Eli Lilly Agreement
Hims & Hers Rises as Lilly Expands Weight-Loss Drug Access Through Platform
Reuters  ·  11-06 20:08
Hims & Hers Rises as Lilly Expands Weight-Loss Drug Access Through Platform
Hims & Hers Shares up 7.5% Premarket as Lilly to Sell Its Obesity Drugs on Co's Platform
THOMSON REUTERS  ·  11-06 19:51
Hims & Hers Shares up 7.5% Premarket as Lilly to Sell Its Obesity Drugs on Co's Platform
Movement Alert｜Hims & Hers Health Inc. Rises 6.36% in Pre-Market Trading, Earnings Expectations Help Offset Litigation Overhang
Market Focus  ·  11-06 19:49
Movement Alert｜Hims & Hers Health Inc. Rises 6.36% in Pre-Market Trading, Earnings Expectations Help Offset Litigation Overhang
Eli Lilly: Hims & Hers Has Committed not to Offer Access to Compounded Copies of Lilly’s Glp-1S in Future
THOMSON REUTERS  ·  11-06 19:45
Eli Lilly: Hims & Hers Has Committed not to Offer Access to Compounded Copies of Lilly’s Glp-1S in Future
Eli Lilly: Co, Hims & Hers Health Announced Agreement to Help Expand Access to Zepbound (Tirzepatide) & Foundayo (Orforglipron)
THOMSON REUTERS  ·  11-06 19:45
Eli Lilly: Co, Hims & Hers Health Announced Agreement to Help Expand Access to Zepbound (Tirzepatide) & Foundayo (Orforglipron)
Lilly to Sell Obesity Drugs Directly on Hims & Hers Site
Reuters  ·  11-06 19:45
Lilly to Sell Obesity Drugs Directly on Hims & Hers Site
Eli Lilly: Agreement Gives Patients Path to FDA-Approved Treatments at Self-Pay Price Through the Hims & Hers Platform
THOMSON REUTERS  ·  11-06 19:45
Eli Lilly: Agreement Gives Patients Path to FDA-Approved Treatments at Self-Pay Price Through the Hims & Hers Platform
Movement Alert｜Hims & Hers Health Inc. Falls 5.18% in Regular Trading, FTC Complaint and Billing Dispute Concerns Weigh on Sentiment
Market Focus  ·  11-05 22:58
Movement Alert｜Hims & Hers Health Inc. Falls 5.18% in Regular Trading, FTC Complaint and Billing Dispute Concerns Weigh on Sentiment
Movement Alert｜Hims & Hers Health Inc. Intraday Rise 6.16% in Regular Trading, Earnings Preview Supports Sentiment Despite Ongoing FTC Overhang
Market Focus  ·  11-04 23:23
Movement Alert｜Hims & Hers Health Inc. Intraday Rise 6.16% in Regular Trading, Earnings Preview Supports Sentiment Despite Ongoing FTC Overhang
Movement Alert｜Hims & Hers Health Inc. Falls 5.22% in Regular Trading, FTC lawsuit and subscription billing dispute remain overhangs
Market Focus  ·  11-03
Movement Alert｜Hims & Hers Health Inc. Falls 5.22% in Regular Trading, FTC lawsuit and subscription billing dispute remain overhangs
Movement Alert｜Hims & Hers Health Inc. Falls 5.09% in Regular Trading, FTC Complaint Response Remains in Focus
Market Focus  ·  10-30
Movement Alert｜Hims & Hers Health Inc. Falls 5.09% in Regular Trading, FTC Complaint Response Remains in Focus
24H | Nasdaq Futures Fall 1.5%; Micron Slides 3%; Coinbase Sinks 5%; Amazon, AMD Drop over 6%; Reddit Plunges 18%; Intel Tumbles 23%
US Overnight  ·  10-30
24H | Nasdaq Futures Fall 1.5%; Micron Slides 3%; Coinbase Sinks 5%; Amazon, AMD Drop over 6%; Reddit Plunges 18%; Intel Tumbles 23%
Hims & Hers Climbs on Potential to Sell Some Unapproved Peptides
Reuters  ·  10-29
Hims & Hers Climbs on Potential to Sell Some Unapproved Peptides
Movement Alert｜Hims & Hers Health Inc. Intraday Rise 5.19% in Regular Trading, FTC Complaint Response Draws Market Focus
Market Focus  ·  10-29
Movement Alert｜Hims & Hers Health Inc. Intraday Rise 5.19% in Regular Trading, FTC Complaint Response Draws Market Focus
The U.S. Government Will no Longer Penalize American Companies for Making Six Popular Peptides
Dow Jones  ·  10-29
The U.S. Government Will no Longer Penalize American Companies for Making Six Popular Peptides

Introduction

Company Name.
Hims & Hers Health Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Issue price:
--